327 related articles for article (PubMed ID: 22399852)
21. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
[TBL] [Abstract][Full Text] [Related]
22. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.
Jereb M; Kotar T
Wien Klin Wochenschr; 2006 Apr; 118(5-6):170-4. PubMed ID: 16773483
[TBL] [Abstract][Full Text] [Related]
24. [Procalcitonin - a marker for managing antibiotic therapies?].
Krawtchenko N; Franzen D; Müller B
Praxis (Bern 1994); 2014 Feb; 103(4):187-93; quiz 194-5. PubMed ID: 24518234
[No Abstract] [Full Text] [Related]
25. [Procalcitonin as a biomarker in infections].
Christ-Crain M
Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
[No Abstract] [Full Text] [Related]
26. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
28. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
Martinez FJ; Curtis JL
Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
[No Abstract] [Full Text] [Related]
29. [Procalcitonin as a marker of severe bacterial infection in children].
Schrøder H; Lodahl D
Ugeskr Laeger; 2004 Oct; 166(43):3804-7. PubMed ID: 15544109
[No Abstract] [Full Text] [Related]
30. Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.
El-Solh AA; Vora H; Knight PR; Porhomayon J
Crit Care Med; 2011 Jun; 39(6):1251-6. PubMed ID: 21283001
[TBL] [Abstract][Full Text] [Related]
31. Procalcitonin in pediatrics for differentiation of bacterial and viral infections.
Gendrel D; Bohuon C
Intensive Care Med; 2000 Mar; 26 Suppl 2():S178-81. PubMed ID: 18470716
[No Abstract] [Full Text] [Related]
32. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
Ugajin M; Yamaki K; Hirasawa N; Yagi T
Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.
Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A
Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149
[TBL] [Abstract][Full Text] [Related]
34. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
[TBL] [Abstract][Full Text] [Related]
35. Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study.
van Geffen WH; Bruins M; Kerstjens HA
J Breath Res; 2016 Jun; 10(3):036001. PubMed ID: 27310311
[TBL] [Abstract][Full Text] [Related]
36. The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study.
Nouvenne A; Ticinesi A; Folesani G; Cerundolo N; Prati B; Morelli I; Guida L; Lauretani F; Maggio M; Aloe R; Lippi G; Meschi T
BMC Geriatr; 2016 Jan; 16():16. PubMed ID: 26772604
[TBL] [Abstract][Full Text] [Related]
37. Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease.
Yin T; Zhu Z; Mei Z; Feng J; Zhang W; He Y; Shi J; Qian L; Liu Y; Huang Q; Hu Y; Jie Z
Clin Respir J; 2018 Mar; 12(3):1228-1239. PubMed ID: 28586150
[TBL] [Abstract][Full Text] [Related]
38. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study.
Cuquemelle E; Soulis F; Villers D; Roche-Campo F; Ara Somohano C; Fartoukh M; Kouatchet A; Mourvillier B; Dellamonica J; Picard W; Schmidt M; Boulain T; Brun-Buisson C;
Intensive Care Med; 2011 May; 37(5):796-800. PubMed ID: 21369807
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin elevation suggests a septic source.
Friend KE; Burgess JN; Britt RC; Collins JN; Weireter LN; Novosel TJ; Britt LD
Am Surg; 2014 Sep; 80(9):906-9. PubMed ID: 25197879
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Qian W; Huang GZ
Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
